- Home
- ORKA vs ASTL Comparison
ORKA vs ASTL Comparison
Compare ORKA & ASTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORKA
- ASTL
- Stock Information
- Founded
- ORKA 2004
- ASTL 1902
- Country
- ORKA United States
- ASTL Canada
- Employees
- ORKA N/A
- ASTL N/A
- Industry
- ORKA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- ASTL Steel/Iron Ore
- Sector
- ORKA Health Care
- ASTL Industrials
- Exchange
- ORKA Nasdaq
- ASTL Nasdaq
- Market Cap
- ORKA 354.2M
- ASTL 532.0M
- IPO Year
- ORKA N/A
- ASTL N/A
- Fundamental
- Price
- ORKA $11.31
- ASTL $6.67
- Analyst Decision
- ORKA Strong Buy
- ASTL
- Analyst Count
- ORKA 8
- ASTL 0
- Target Price
- ORKA $39.71
- ASTL N/A
- AVG Volume (30 Days)
- ORKA 328.9K
- ASTL 1.4M
- Earning Date
- ORKA 08-15-2025
- ASTL 07-07-2025
- Dividend Yield
- ORKA N/A
- ASTL 2.87%
- EPS Growth
- ORKA N/A
- ASTL N/A
- EPS
- ORKA N/A
- ASTL N/A
- Revenue
- ORKA N/A
- ASTL $1,635,857,227.00
- Revenue This Year
- ORKA N/A
- ASTL $0.95
- Revenue Next Year
- ORKA N/A
- ASTL $21.63
- P/E Ratio
- ORKA N/A
- ASTL N/A
- Revenue Growth
- ORKA N/A
- ASTL N/A
- 52 Week Low
- ORKA $5.49
- ASTL $4.17
- 52 Week High
- ORKA $52.32
- ASTL $12.14
- Technical
- Relative Strength Index (RSI)
- ORKA N/A
- ASTL 60.58
- Support Level
- ORKA N/A
- ASTL $6.68
- Resistance Level
- ORKA N/A
- ASTL $7.03
- Average True Range (ATR)
- ORKA 0.00
- ASTL 0.35
- MACD
- ORKA 0.00
- ASTL 0.04
- Stochastic Oscillator
- ORKA 0.00
- ASTL 70.73
About ORKA Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its lead program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. The company's co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, psoriatic arthritis (PsA), and other conditions. These programs each bind their respective targets at high affinity and incorporate half-life extension technology to increase exposure and decreasing dosing frequency.
About ASTL Algoma Steel Group Inc.
Algoma Steel Group Inc is a fully integrated steel producer of hot and cold rolled steel products, including coiled sheet and plate, strategically located. The firm operates in a single segment of basic steel production including sheets, plates, slabs, and freights. The company's revenue is generated from contracts to produce, ship, and deliver steel products Geographically it serves Canada, the United States, and the rest of the world, whilst driving key revenue from domestic sales. The company generates the majority of its revenue from the sale of Steel sheets and strips.